GSA CAPITAL PARTNERS LLP

Position in OPK — Opko Health, Inc.

CIK 1362033 LONDON, X0

Position in OPK

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$756,622

-$26,251 QoQ

Shares Held

663,704

+6.8% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $12,036,211 across 17 Diagnostics & Research names. OPK ranks #6 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	13,542	$2,567,563
2	IDXX	Idexx Laboratories Inc /De	2,801	$1,573,853
3	MYGN	Myriad Genetics Inc	339,902	$1,529,559
4	A	Agilent Technologies, Inc.	8,721	$994,019
5	XGN	Exagen Inc.	253,005	$759,015
6	OPK	Opko Health, Inc. This page	663,704	$756,622
7	BDSX	Biodesix Inc	39,406	$571,387
8	PSNL	Personalis, Inc.	82,175	$523,454

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$756,622	663,704	+6.8%	Shares	Sole	2026-05-08
2025-12-31	$782,873	621,328	-53.8%	Shares	Sole	2026-02-06
2025-03-31	$2,230,543	1,343,701	+24.2%	Shares	Sole	2025-05-08
2024-12-31	$1,590,842	1,082,206	+1133.5%	Shares	Sole	2025-02-07
2022-12-31	$109,672	87,738	+33.7%	Shares	Sole	2023-02-13
2021-12-31	$315,555	65,604	+372.2%	Shares	Sole	2022-02-14
2021-03-31	$59,596	13,892	-48.5%	Shares	Sole	2021-05-10
2020-12-31	$106,598	26,987	-87.3%	Shares	Sole	2021-02-03
2020-09-30	$783,434	212,313	+678.4%	Shares	Sole	2020-11-06
2020-06-30	$93,011	27,276	-92.7%	Shares	Sole	2020-08-11
2020-03-31	$500,350	373,396	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.